ConductScience.org, home

Paper3691595

Factors responsible for interindividual differences in the dose requirement of phenprocoumon.

Trenk D and 4 others. Eur J Clin Pharmacol, 1987. Cited by 12 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Factors responsible for interindividual differences in the dose requirement of phenprocoumon. Papers, record 3691595. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3691595

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Factors responsible for interindividual differences in the dose requirement of phenprocoumon.
PubMed
Journal
Eur J Clin Pharmacol
PubMed
Year
1987
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
0.55
iCite
Revised in PubMed
2019-08-13
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Trenk DD
2Althen HH
3Jähnchen EE
4Meinertz TT
5Oie SS

Source PubMed

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
4-HydroxycoumarinsMajor topic
PhenprocoumonMajor topic
Coronary Thrombosis
Female
Humans
Individuality
Male
Middle Aged
Protein Binding
Prothrombin Time

Source PubMed

References13

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11,277,711Serum protein binding as a determinant of warfarin body clearance and anticoagulant effect.Clin Pharmacol Ther1976https://conductscience.org/library/papers/1277711PubMed
2880,974Individual variation in the response to phenprocoumon.Eur J Clin Pharmacol1977https://conductscience.org/library/papers/880974PubMed
34,192,279Some aspects of the pharmacology of oral anticoagulants.Clin Pharmacol Ther1970https://conductscience.org/library/papers/4192279PubMed
41,164,821Commentary: a physiological approach to hepatic drug clearance.Clin Pharmacol Ther1975https://conductscience.org/library/papers/1164821PubMed
55,339,022The pharmacological basis of oral anticoagulant therapy.Thromb Diath Haemorrh Suppl1966https://conductscience.org/library/papers/5339022PubMed
65,708,146Properties of 3-(1-phenyl-propyl)-4-oxycoumarin (marcoumar) in the plasma when tested in normal cases and under the influence of drugs.Thromb Diath Haemorrh1968https://conductscience.org/library/papers/5708146PubMed
73,901,045Aging and drug disposition: an update.Pharmacol Rev1985https://conductscience.org/library/papers/3901045PubMed
8958,506Pharmacokinetics of phenprocoumon in man investigated using a gas chromatographic method of drug analysis.Naunyn Schmiedebergs Arch Pharmacol1976https://conductscience.org/library/papers/958506PubMed
9497,091Pharmacokinetics and pharmacodynamics of warfarin at steady state.Br J Clin Pharmacol1979https://conductscience.org/library/papers/497091PubMed
10303,522[Pharmacokinetic aspects of overdosage and intoxication with oral anticoagulant drugs (author's transl)].Arzneimittelforschung1977https://conductscience.org/library/papers/303522PubMed
114,593,987[Drugs interacting with coumarine oral anticoagulants (author's transl)].Klin Wochenschr1973https://conductscience.org/library/papers/4593987PubMed
126,341,026Drug metabolism in the elderly: confounding of age, smoking, and ethanol effects.Drug Metab Rev1983https://conductscience.org/library/papers/6341026PubMed
13954,354The enantiomers of phenprocoumon: pharmacodynamic and pharmacokinetic studies.Clin Pharmacol Ther1976https://conductscience.org/library/papers/954354PubMed

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
23,519,598Quantifying the effect of covariates on concentrations and effects of steady-state phenprocoumon using a population pharmacokinetic/pharmacodynamic model.Clin Pharmacokinet2013https://conductscience.org/library/papers/23519598PubMed
16,847,664Obesity is associated with a slower response to initial phenprocoumon therapy whereas CYP2C9 genotypes are not.Eur J Clin Pharmacol2006https://conductscience.org/library/papers/16847664PubMed
16,372,822Comparative pharmacokinetics of vitamin K antagonists: warfarin, phenprocoumon and acenocoumarol.Clin Pharmacokinet2005https://conductscience.org/library/papers/16372822PubMed
8,792,056Clinically important drug interactions with anticoagulants. An update.Clin Pharmacokinet1996https://conductscience.org/library/papers/8792056PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3691595

GET https://conductscience.org/api/papers/v1/3691595/authors